Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

AstraZeneca synthesizes amide derivatives as cytokine production inhibitors

March 22, 2000

Lilly discloses new indole sPLA2 inhibitors

March 21, 2000

More good news about Enbrel: NEJM article describes efficacy in juvenile RA

March 20, 2000

Amides synthesized at AstraZeneca useful for cytokine-mediated diseases

March 17, 2000

Collgard receives orphan drug status for scleroderma therapy

March 15, 2000

New inhibitors of NOS, particularly iNOS, in early development at AstraZeneca

March 14, 2000

CE Mark granted for the Prosorba Column as rheumatoid arthritis Rx

March 14, 2000

Suntory's new antiinflammatory agents act as inhibitors of NF-kB

March 13, 2000

Taisho presents new series of cytokine production inhibitors

March 10, 2000

New nondrug treatment approved for rheumatoid arthritis in Canada

March 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.